|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61P 17/00 | |||
| A61P 17/12 |
| (11) | Number of the document | 1691830 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04813630.3 |
| Date of filing the European patent application | 2004-12-08 | |
| (97) | Date of publication of the European application | 2006-08-23 |
| (45) | Date of publication and mention of the grant of the patent | 2007-08-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/041327 |
| Date | 2004-12-08 |
| (87) | Number | WO 2005/056050 |
| Date | 2005-06-23 |
| (30) | Number | Date | Country code |
| 731973 | 2003-12-09 | US |
| (72) |
FIRST, Eric, R., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine CA 92612,
US
|
| (54) | BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS |
| BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS |